The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(1-(4-methyl-3-(6-(4-methylpiperazin-1-yl)-3H-imidazo[4,5-c]pyridin-2-yl)benzoyl)piperidin-4-yl)benzonitrile ID: ALA2322367
PubChem CID: 70873969
Max Phase: Preclinical
Molecular Formula: C31H33N7O
Molecular Weight: 519.65
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(C(=O)N2CCC(c3ccc(C#N)cc3)CC2)cc1-c1nc2cc(N3CCN(C)CC3)ncc2[nH]1
Standard InChI: InChI=1S/C31H33N7O/c1-21-3-6-25(31(39)38-11-9-24(10-12-38)23-7-4-22(19-32)5-8-23)17-26(21)30-34-27-18-29(33-20-28(27)35-30)37-15-13-36(2)14-16-37/h3-8,17-18,20,24H,9-16H2,1-2H3,(H,34,35)
Standard InChI Key: FKIWVNDNCVARLD-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 44 0 0 0 0 0 0 0 0999 V2000
6.2328 -3.6062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1945 -3.0045 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1969 -1.5045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8991 -0.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5987 -1.5004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5965 -3.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8943 -3.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3115 2.9665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8032 3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4133 1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5536 4.4230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0507 4.3052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8964 5.5441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2462 6.8959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7505 7.0088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9049 5.7699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7082 5.8598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.3932 5.4343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.9152 4.3538 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.2375 6.6751 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-8.7337 6.5675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.5750 7.8093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.9202 9.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4241 9.2665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5827 8.0247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.7619 10.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.2583 10.2961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.0977 11.5392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.4407 12.8877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.9444 12.9931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.1051 11.7499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.2806 14.1316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9520 15.1261 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 2 1 0
5 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 10 2 0
14 15 1 0
15 16 2 0
16 8 1 0
12 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
22 23 1 0
19 24 1 0
24 25 2 0
24 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 26 1 0
29 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 32 1 0
35 38 1 0
38 39 3 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 519.65Molecular Weight (Monoisotopic): 519.2747AlogP: 4.58#Rotatable Bonds: 4Polar Surface Area: 92.15Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.59CX Basic pKa: 7.63CX LogP: 4.55CX LogD: 4.13Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.42Np Likeness Score: -1.57
References 1. Oslob JD, Johnson RJ, Cai H, Feng SQ, Hu L, Kosaka Y, Lai J, Sivaraja M, Tep S, Yang H, Zaharia CA, Evanchik MJ, McDowell RS.. (2013) Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation., 4 (1): [PMID:24900571 ] [10.1021/ml300335r ] 2. (2014) Heterocyclic modulators of lipid synthesis,